<DOC>
	<DOCNO>NCT02872311</DOCNO>
	<brief_summary>This open-label , randomized trial 180 adult age 65-74 year evaluate immune response standard dose , high dose , adjuvanted influenza vaccine across 2 season . Participants randomize receive 1 3 license recommend vaccine pre post-vaccination serum blood draw total 6 draw 18 month .</brief_summary>
	<brief_title>Open-Label Influenza Vaccine Evaluation</brief_title>
	<detailed_description />
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Age 6574 year time study enrollment ambulatory live select Wisconsin community surround community . Willing able give inform consent prior study enrollment Able comply study requirement . Prior receipt 201617 influenza vaccine Current participation another clinical trial Presence contraindication influenza vaccine</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>74 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Vaccine</keyword>
	<keyword>Influenza</keyword>
	<keyword>High Dose</keyword>
	<keyword>Adjuvanted</keyword>
</DOC>